Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mathilde Latreille-Barbier"'
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 11, Pp 2674-2677 (2017)
An inactivated split-virion trivalent influenza vaccine (IIV3; Vaxigrip®, Sanofi Pasteur) has been available globally since 1968. Here, we describe the results of an open-label, post-licensure trial (EudraCT no. 2014-005078-12) to confirm the immuno
Externí odkaz:
https://doaj.org/article/6cf57ac016944973ad180080db37e806
Autor:
Xavier Pelletier, Mathilde Latreille-Barbier, Alvin Ibarra, Arthur C. Ouwehand, Yves Donazzolo
Publikováno v:
Gut Microbes
Bifidobacterium animalis subsp. lactis HN019 (HN019) ameliorates chronic idiopathic constipation. Our aim was to determine the efficacy and safety of 28-day supplementation with 1 × 109 or 1 × 1010 CFU of HN019/day for constipation. A total of 228
Publikováno v:
Human Vaccines & Immunotherapeutics
An inactivated split-virion trivalent influenza vaccine (IIV3; Vaxigrip®, Sanofi Pasteur) has been available globally since 1968. Here, we describe the results of an open-label, post-licensure trial (EudraCT no. 2014-005078-12) to confirm the immuno
Autor:
Mathilde Latreille-Barbier, Alvin Ibarra, Arthur C. Ouwehand, Xavier Pelletier, Yves Donazzolo
Publikováno v:
American Journal of Gastroenterology. 112:S243